Qanatpharma (QP) is a Phase 2 clinical-stage biopharma company developing innovative therapies for diseases where microvascular dysfunction is a central feature. QP manages a pipeline that spans from microvascular target discovery and validation via AI-driven drug development to preclinical studies and, ultimately, clinical trials.
Company Details
- Employees
- 10
- Address
- Alter Postplatz 2, Stans,6370,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.qanatpharma.com
- Keywords
- Berlin.
- HQ
- Stans
Qanatpharma Questions
Qanatpharma's website is http://www.qanatpharma.com
Qanatpharma's LinkedIn profile is https://ch.linkedin.com/company/qanatpharma
Qanatpharma has
10 employees.
View email and phone details for 10
employees at Qanatpharma.
Qanatpharma's industry is
Pharmaceutical Manufacturing
Qanatpharma's top competitors are
Ted Rogers Centre For Heart Research,
Recursion,
Aphaia Pharma,
The Art Of Quality Podcast,
Enamine Ltd.,
Proteros Biostructures Gmbh,
Deep Genomics,
Wtw,
Nordwind Growth,
Zuse Institute Berlin.
Qanatpharma's categories are Pharmaceutical Manufacturing
